1253 related articles for article (PubMed ID: 29632013)
1. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
2. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
3. Impact of
Sharma D; Paul RA; Rudramurthy SM; Kashyap N; Bhattacharya S; Soman R; Shankarnarayan SA; Chavan D; Singh S; Das P; Kaur H; Ghosh AK; Prasad R; Sanyal K; Chakrabarti A
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0165221. PubMed ID: 34780273
[TBL] [Abstract][Full Text] [Related]
4. Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance.
Kordalewska M; Cancino-Prado G; Nobrega de Almeida Júnior J; Brasil Brandão I; Tigulini de Souza Peral R; Colombo AL; Perlin DS
Antimicrob Agents Chemother; 2023 Jun; 67(6):e0042323. PubMed ID: 37222585
[TBL] [Abstract][Full Text] [Related]
5. Rezafungin
Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
[TBL] [Abstract][Full Text] [Related]
6. Rapid Detection of
Hou X; Lee A; Jiménez-Ortigosa C; Kordalewska M; Perlin DS; Zhao Y
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397051
[No Abstract] [Full Text] [Related]
7. Spontaneous Mutational Frequency and
Shields RK; Kline EG; Healey KR; Kordalewska M; Perlin DS; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
[TBL] [Abstract][Full Text] [Related]
8. Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to
Hirayama T; Miyazaki T; Sumiyoshi M; Ito Y; Ashizawa N; Takeda K; Iwanaga N; Takazono T; Yamamoto K; Izumikawa K; Yanagihara K; Makimura K; Tsukamoto K; Kohno S; Mukae H
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0124322. PubMed ID: 36920237
[TBL] [Abstract][Full Text] [Related]
9.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
10. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
11. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
[TBL] [Abstract][Full Text] [Related]
12. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains.
Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA
Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396
[TBL] [Abstract][Full Text] [Related]
13. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
[TBL] [Abstract][Full Text] [Related]
14. Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates.
Spruijtenburg B; Ahmad S; Asadzadeh M; Alfouzan W; Al-Obaid I; Mokaddas E; Meijer EFJ; Meis JF; de Groot T
Mycoses; 2023 Dec; 66(12):1079-1086. PubMed ID: 37712885
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.
Lepak A; Castanheira M; Diekema D; Pfaller M; Andes D
Antimicrob Agents Chemother; 2012 Nov; 56(11):5875-82. PubMed ID: 22948870
[TBL] [Abstract][Full Text] [Related]
16. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomics and Phenotyping Define Genetic Signatures Associated with Echinocandin Resistance in Candida auris.
Jenull S; Shivarathri R; Tsymala I; Penninger P; Trinh PC; Nogueira F; Chauhan M; Singh A; Petryshyn A; Stoiber A; Chowdhary A; Chauhan N; Kuchler K
mBio; 2022 Aug; 13(4):e0079922. PubMed ID: 35968956
[TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
Arendrup MC; Perlin DS; Jensen RH; Howard SJ; Goodwin J; Hope W
Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305
[TBL] [Abstract][Full Text] [Related]
20. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
